Tsung-Ying Yang - JoVE Visualize

Showing results (91-100 of 174) with videos related to

Pageof 18

Sort By:

Journal of Clinical Medicine|January 8, 2023

Reactivation of Hepatitis B Virus in Lung Cancer Patients Receiving Tyrosine Kinase Inhibitor TreatmentPo-Hsin Lee, Yen-Hsiang Huang, Yu-Wei Hsu, et al.

Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|March 8, 2021

Activities of imipenem-relebactam combination against carbapenem-nonsusceptible Enterobacteriaceae in TaiwanTsung-Ying Yang, Ya-Ju Hsieh, Li-Ting Kao, et al.

International Dental Journal|June 4, 2026

A Longitudinal Study of Antimicrobial Resistance in Oral Bacterial Isolates From Periodontitis Patients in TaiwanJung-Chang Kung, Chern-Hsiung Lai, Ping-Ho Chen, et al.

Medicine|June 17, 2022

Characteristics and immune checkpoint inhibitor effects on non-smoking non-small cell lung cancer with KRAS mutation: A single center cohort (STROBE-compliant)Jia-Jun Wu, Po-Hsin Lee, Zhe-Rong Zheng, et al.

Journal of Infection and Public Health|March 20, 2025

Real-world use and treatment outcomes of ceftazidime-avibactam in gram-negative bacterial infection in Taiwan: A multicenter retrospective studyTsung-Ying Yang, Ching-Tai Huang, Po-Yu Liu, et al.

Plos One|August 18, 2022

Various impacts of driver mutations on the PD-L1 expression of NSCLCCheng-Hsiang Chu, Yen-Hsiang Huang, Po-Hsin Lee, et al.

Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 24, 2018

Characteristics and Predictive Value of PD-L1 Status in Real-World Non-Small Cell Lung Cancer PatientsJeng-Sen Tseng, Tsung-Ying Yang, Chih-Ying Wu, et al.

Antimicrobial Agents and Chemotherapy|June 12, 2026

Molecular epidemiology and emerging <i>tet</i>(X)-associated resistance of <i>Elizabethkingia</i> spp. in Taiwan, 2016-2022Yu-Tsung Huang, Cheng-Yen Kao, Han-Yueh Kuo, et al.

JCO Precision Oncology|September 30, 2024

Using a Polygenic Risk Score to Improve the Risk Prediction of Non-Small Cell Lung Cancer in TaiwanPo-Hsin Lee, I-Chieh Chen, Yi-Ming Chen, et al.

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2014

Dynamic plasma EGFR mutation status as a predictor of EGFR-TKI efficacy in patients with EGFR-mutant lung adenocarcinomaJeng-Sen Tseng, Tsung-Ying Yang, Chi-Ren Tsai, et al.

Pageof 18

Showing results (91-100 of 174) with videos related to

Sort By:

Pageof 18

Journal of Clinical Medicine|January 8, 2023

Reactivation of Hepatitis B Virus in Lung Cancer Patients Receiving Tyrosine Kinase Inhibitor TreatmentPo-Hsin Lee, Yen-Hsiang Huang, Yu-Wei Hsu, et al.

Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|March 8, 2021

Activities of imipenem-relebactam combination against carbapenem-nonsusceptible Enterobacteriaceae in TaiwanTsung-Ying Yang, Ya-Ju Hsieh, Li-Ting Kao, et al.

International Dental Journal|June 4, 2026

A Longitudinal Study of Antimicrobial Resistance in Oral Bacterial Isolates From Periodontitis Patients in TaiwanJung-Chang Kung, Chern-Hsiung Lai, Ping-Ho Chen, et al.

Medicine|June 17, 2022

Characteristics and immune checkpoint inhibitor effects on non-smoking non-small cell lung cancer with KRAS mutation: A single center cohort (STROBE-compliant)Jia-Jun Wu, Po-Hsin Lee, Zhe-Rong Zheng, et al.

Journal of Infection and Public Health|March 20, 2025

Real-world use and treatment outcomes of ceftazidime-avibactam in gram-negative bacterial infection in Taiwan: A multicenter retrospective studyTsung-Ying Yang, Ching-Tai Huang, Po-Yu Liu, et al.

Plos One|August 18, 2022

Various impacts of driver mutations on the PD-L1 expression of NSCLCCheng-Hsiang Chu, Yen-Hsiang Huang, Po-Hsin Lee, et al.

Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 24, 2018

Characteristics and Predictive Value of PD-L1 Status in Real-World Non-Small Cell Lung Cancer PatientsJeng-Sen Tseng, Tsung-Ying Yang, Chih-Ying Wu, et al.

Antimicrobial Agents and Chemotherapy|June 12, 2026

Molecular epidemiology and emerging <i>tet</i>(X)-associated resistance of <i>Elizabethkingia</i> spp. in Taiwan, 2016-2022Yu-Tsung Huang, Cheng-Yen Kao, Han-Yueh Kuo, et al.

JCO Precision Oncology|September 30, 2024

Using a Polygenic Risk Score to Improve the Risk Prediction of Non-Small Cell Lung Cancer in TaiwanPo-Hsin Lee, I-Chieh Chen, Yi-Ming Chen, et al.

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2014

Dynamic plasma EGFR mutation status as a predictor of EGFR-TKI efficacy in patients with EGFR-mutant lung adenocarcinomaJeng-Sen Tseng, Tsung-Ying Yang, Chi-Ren Tsai, et al.

Pageof 18